Metro Alliance Holdings & Equities Corp. (PSE:MAHB)

Ligand Pharmaceuticals Cash Flow Statement

Financials in millions PHP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-0.18	2.6	-4.78	3.32	-165.08	0.2
Depreciation & Amortization	24.69	24.94	39.31	42.74	37.18	34.49
Other Amortization	0.31	0.31	0.28	-	-	-
Loss (Gain) From Sale of Assets	-1.15	-1.15	-0.16	-	-	-
Provision & Write-off of Bad Debts	-	-	-	-	-	1.52
Other Operating Activities	12.6	13.25	5.73	19.27	186.35	14.72
Change in Accounts Receivable	37.75	12.58	12.3	-3.13	-7.85	-22.8
Change in Accounts Payable	-11.56	-8.22	-19.34	0.28	-3.37	17.03
Change in Other Net Operating Assets	-1.16	-1.92	-7.67	-9.4	1.9	-16.65
Operating Cash Flow	61.31	42.39	25.67	53.08	49.12	28.51
Operating Cash Flow Growth	110.49%	65.13%	-51.64%	8.06%	72.26%	6.36%
Capital Expenditures	-1.48	-3.14	-2.15	-10.5	-12.57	-1.42
Sale of Property, Plant & Equipment	1.39	1.39	0.3	-	-	-
Sale (Purchase) of Intangibles	-3.37	-3.99	-0.04	-0.23	-0.08	-0.76
Investment in Securities	-	-	-	-	-	2.04
Other Investing Activities	0.11	0.11	-5.36	0.07	4.92	-210.72
Investing Cash Flow	-3.34	-5.63	-7.25	-10.65	-7.73	-210.87
Long-Term Debt Issued	-	5.54	5.92	5.91	0.91	215.41
Total Debt Issued	5.55	5.54	5.92	5.91	0.91	215.41
Long-Term Debt Repaid	-	-22.94	-27.81	-35.32	-32.33	-29.43
Total Debt Repaid	-22.25	-22.94	-27.81	-35.32	-32.33	-29.43
Net Debt Issued (Repaid)	-16.7	-17.4	-21.89	-29.41	-31.42	185.98
Other Financing Activities	-	-	-	-	-2.63	-3.5
Financing Cash Flow	-16.7	-17.4	-21.89	-29.41	-34.05	182.47
Net Cash Flow	43.46	19.36	-3.47	13.01	7.34	0.12
Free Cash Flow	59.83	39.25	23.51	42.58	36.54	27.1
Free Cash Flow Growth	126.90%	66.90%	-44.78%	16.52%	34.87%	-
Free Cash Flow Margin	33.41%	19.74%	9.67%	12.74%	12.45%	9.90%
Free Cash Flow Per Share	0.17	0.13	0.08	0.14	0.12	0.09
Cash Interest Paid	-	-	-	-	2.63	3.5
Levered Free Cash Flow	42.16	26.11	24.22	40.54	-111.39	28.01
Unlevered Free Cash Flow	42.84	26.78	25.14	42.26	-109.75	30.2
Change in Net Working Capital	-22.49	-5.83	11.63	2.76	4.64	9.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.